BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,040,590 | +195.6% | 308,178 | +163.2% | 1.41% | +176.0% |
| Q1 2023 | $4,749,576 | +21.9% | 117,100 | +141.9% | 0.51% | +141.5% |
| Q2 2021 | $3,896,000 | -35.1% | 48,400 | -32.0% | 0.21% | -20.9% |
| Q1 2021 | $6,005,000 | -47.5% | 71,200 | -50.1% | 0.27% | -67.0% |
| Q4 2020 | $11,442,000 | -19.8% | 142,600 | -19.6% | 0.81% | -20.8% |
| Q3 2020 | $14,258,000 | -28.1% | 177,300 | -25.2% | 1.03% | -39.4% |
| Q4 2019 | $19,823,000 | +65.6% | 237,060 | +73.2% | 1.69% | +70.9% |
| Q3 2019 | $11,971,000 | +22.7% | 136,860 | +14.9% | 0.99% | +3.4% |
| Q2 2019 | $9,758,000 | +1328.7% | 119,150 | +673.7% | 0.96% | +2026.7% |
| Q4 2016 | $683,000 | -85.5% | 15,400 | -84.4% | 0.04% | -81.7% |
| Q3 2016 | $4,712,000 | +767.8% | 99,000 | +725.0% | 0.25% | +748.3% |
| Q2 2016 | $543,000 | – | 12,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |